Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Short bowel syndrome mouse microbiome

ABSTRACT: Short bowel syndrome mouse microbiome

PROVIDER: PRJEB26648 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2570100_1.fastq.gz	Fastqsanger.gz
	ERR2570100_2.fastq.gz	Fastqsanger.gz
	ERR2570110_1.fastq.gz	Fastqsanger.gz
	ERR2570110_2.fastq.gz	Fastqsanger.gz
	ERR2570120_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 126

Similar Datasets

Gut microbiome dynamics in short bowel syndrome mice

Project description:Gut microbiome dynamics in short bowel syndrome mice

| PRJEB52226 | ENA

Gastrointestinal microbiota of children with short bowel syndrome

Project description:Gastrointestinal microbiota of children with short bowel syndrome Targeted loci environmental

| PRJNA492751 | ENA

Satb2 deletion in colon approach to treat short bowel syndrome

Project description:Satb2 deletion in colon approach to treat short bowel syndrome

| PRJNA1174226 | ENA

Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome (16S)

Project description:Changes in microbiome composition have been associated with a wide array of human diseases, turning the human microbiota into an attractive target for therapeutic intervention. Yet clinical translation of these findings requires the establishment of causative connections between specific microbial taxa and their functional impact on host tissues. Here, we infused gut organ cultures with longitudinal microbiota samples collected from therapy-naïve irritable bowel syndrome (IBS) patients under low-FODMAP (fermentable Oligo-, Di-, Mono-saccharides and Polyols) diet. We show that post-diet microbiota regulates intestinal expression of inflammatory and neuro-muscular gene-sets. Specifically, we identify Bifidobacterium adolescentis as a diet-sensitive pathobiont that alters tight junction integrity and disrupts gut barrier functions. Collectively, we present a unique pathway discovery approach for mechanistic dissection and identification of functional diet-host-microbiota modules. Our data support the hypothesis that the gut microbiota mediates the beneficial effects of low-FODMAP diet and reinforce the potential feasibility of microbiome based-therapies in IBS.

2022-10-14 | GSE215047 | GEO

Xenotransplanted Human Small Intestinal Organoids Reveal the Transepithelial Zinc Transport Pathway as a Key Mediator of Intestinal Adaptation in Short Bowel Syndrome

Project description:Intestinal adaptation is crucial to improving outcomes in short bowel syndrome (SBS). We performed scRNA sequencing of human intestinal organoid explanted from mice with experimental SBS to examine the genes and pathways involved in this adaptation.

2024-08-16 | GSE271065 | GEO

Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome (RNA-Seq II)

2022-10-14 | GSE215049 | GEO

Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome (RNA-Seq I)

2022-10-14 | GSE215048 | GEO

Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome

Project description:The gut microbiome has been implicated in multiple human chronic gastrointestinal (GI) disorders. Determining its mechanistic role in disease pathogenesis has been difficult due to the apparent disconnect between animal and human studies and a lack of an integrated multi-omics view in the context of disease-specific physiological changes. We integrated longitudinal multi-omics data from the gut microbiome, metabolome, host epigenome and transcriptome in the context of irritable bowel syndrome (IBS) host physiology. We identified IBS subtype-specific and symptom-related variation in microbial composition and function. A subset of identified changes in microbial metabolites correspond to host physiological mechanisms that are relevant to IBS. By integrating multiple data layers, we identified purine metabolism as a novel host-microbial metabolic pathway in IBS with translational potential. Our study highlights the importance of longitudinal sampling and integrating complementary multi-omics data to identify functional mechanisms that can serve as therapeutic targets in a comprehensive treatment strategy for chronic GI diseases.

2020-03-13 | GSE146853 | GEO

Fecal short-chain fatty acids in non-constipated irritable bowel syndrome

Project description:Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis

| PRJEB64301 | ENA

Gut virome and irritable bowel syndrome

Project description:The intestinal virome in irritable bowel syndrome

| PRJEB40590 | ENA